Recent Finacing
Recent Raise
Morphic Therapeutic develops oral integrin small-molecule therapies using a structure-enabled discovery platform, proprietary high-resolution integrin structures, and a Schrödinger partnership for fibrosis, autoimmune, and immuno-oncology programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
